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INTRODUCTION 
 
Methanol extract of Ludwigia Prostrata root 
exhibited antitumour activity against 
Dalton’s ascetic Lymphoma (DAL) in swiss 
albino mice.  The enhancement of median 
survival time by the root extract was 
significant when compare with control 
group. White blood cell count was decreased 
in the treated one with respect to tumour 
bearing mice. 
 
Ludwigia prostrata Roxb 
1 (Neer Kirambu 
in Tamil) belonging to family onagraceae 
was not studied for its medicinal properties 
fully, sofar. Basella alba Linn. of 
Basellaceae is an ingredient of the drug 
sukhaprasavada ghrtam
2 some species of 
Ludwigia are used only as substitute for 
basella.
3 Present study deals with the 
antitumour activity of L. prostrata root. 
 
MATERIALS AND METHODS 
 
Roots of the plant were collected at 
mukkombu, Trichy Dt., Tamilnadu shade 
dried, powdered and finally extracted with 
methanol in a soxhlet.  The extract was 
evaporated to dryness and dissolved in 
phosphate buffer (pH 7.4) and used for the 
present investigation and phytochemical 
screening. 
 
Swiss albino mice having body weight 
between 20-24g were selected for the 
present investigation. The animals were fed 
with standard laboratory diet and water and 
libitum.  Dalton’s Ascitic Lymphoma (DAL) 
cell line was obtained from cancer Research 
Institute, Adayar, Chennai and was 
maintained by weekly transplantation of 10
6 
cells/mouse, intraperitioneally. 
 
EFFECTOFROOTEXTRACTONSURVI
VAL TIME 
 
Animals were inoculated (i.p) with 2 x 10
5 
cells/ mouse on day 0, and treatment with 
root extract started 24 hr after inoculation at 
a dose of 50mg/kg/day i.p ROUP!), 100 
mg/kg/day i.p (group II).  The control 
(group III) was treated with same volume of 
0.9% sodium chloride. All treatment were 
carried out for nine days.  The group V 
animals were treated with standard drug 5- 
Fluorouracil (5U)) 20 mg/kg/day i.p for 9 
days) and median survival times (MST) 
noted for each group.  The animals surviving 
more tan 60 days were considered to be 
cured survival time of treated groups were 
compared with those of control group IV 
(Treated with 5 FU) using the following 
formula
4. 
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          Day of 1st death + Day of last death 
Median survival time (MST)=                           2 
 
      
MST of treated group   
Increase in life span (ILS) = T/C % = MST of control group x100 
 
 
Table 1 Effect of root extract on life span of tumour bearing mice. 
 
Treatment  MST (in days)  Increase in life 
span T/C% 
Root extract (50mg/kg i.p)  26  123.8 
Root extract (100mg/kg i.p)  28  133 
5FU ( 20 mg/kg i.p)  39  185 
Saline 21  100 
 
Number of animals used: 10 in each group 
Days of drug treatment: 9 
 
HAEMATILOGICAL STUDIES  
 
To measure the influence of root extract on  
the hematological status of DAL bearing 
mice, comparison was made among five 
groups (n=5) of mice on the 14
th d after 
inoculation. The groups are (1) tumour 
bearing mice (2) tumour bearing mice 
treated wit root extract (50 mg/kg i.p) for 9 
days (3) tumor bearing mice treated with 
root extract 100 mg/kg/day i.p (4) tumour 
bearing mice treated wt 5 FU (5) normal 
mice. Blood was drawn from the tail vein in 
the conventional was and the red blood cell 
count, white blood cell count, haemoglobin, 
protein and packed cellular volume were 
determine 
5,6 The average of 5 determination 
was computed. 
 
RESULT  
 
The effect of root extract in different 
concentrations on the survival of tumour 
bearing mice showed MST 26 days and 28 
days respectively. MST for control group 
was 21 days and 39 days for the group 
treated with 5 Fu (20mg/kg/day i.p). 
 
Haematological parameters of (Table II) 
tumour bearing mice on day 14 were found 
to be significantly altered from the normal 
group.  Total WBC, protein and P.C.V were 
found to be increased.  The haemoglobin 
content was also reduced.  In the differential 
count of the WBC, the percentage of 
lymphocyte count decrease and the 
neutrophils increased. 
 
When treated with root extract (dose 50 mg) 
and (dose 100mg) increased the RBC, 
haemoglobin and lymphocytes.  They 
decreased WBC, protein and P.C.V The 
curing effect of 5 FU is more than the root 
extracts. 
 
DISCUSSION 
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The curing effect of any anticancer drug is 
measured by the enhancement of the life 
span of the animal7 and the reduction in 
number of white blood cells
8 from the blood.  
The above result of the experiments, i.e 
prolongation of life span and reduction in 
WBC reveal the anticancer effect of the root 
extract of Ludwigia prostrate. 
 
The possible mechanism of action if the root 
extract of L. prostrate ma be due to the 
presence of flavonoids which have been 
reported for ist anticarcinogenic & 
antimutagenic effect, 
9,10 
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CORRIGENDA 
 
WE FORGOT TO MENTION THE AUTHORS NAME IN THE ARTICLES ‘STUDIES 
ON THE ADAPTOGENIC AND ANTIBACTERIAL PROPERTIES OF POLYSCIAS 
FRUTICOSA (l) HARMS “PAGE 231 -246) PUBLISHED TH (VOL NO. XVIII NO 3. & 4 
JANUAR AND APRIL 1999.  THE AUTHORS NAME IS AS HEAD OF TE DEPT. OF 
PHARMACOGNOSY & PHYTOCHEMISTRY, SRI, RAMAKRISHNA COLLEGE OF 
PHARMAC, COIMBATORE-641 044. 
 
OMISSION IS GEGRETTED.  
EDITOR
 
 
 
 
Table II Effect of Root Extract of L. Prostrata on haematological parameters. 
 
Differential count   Total 
RBC 
Million/C
umm. 
Hg 
(g%) 
Total WBC 
Cumm . of blood 
PCV 
(m) 
Protein g% 
  L N  M 
Normal 9.6  ±0.04  14.2± 
0.04 
8018 ±20.99  16.8± 
0.05 
8.7 ±0.08  68 
±0.17 
30 ±0.14  2 ±0.06 
Tumour 
control  
5.83± 0.03  8.3 
±0.04 
13220± 53.74  28.2 
±0.05 
13.8± 0.04  22 
±0.16 
75 ±0.17  3 ±0.10 
5FU (20mg)  8.24 ±0.08  13.8± 
0.04 
9093 ±30.19  17.6 
±0.07 
9.2 ±0.04  42 
±0.37 
56 ±0.26  2 ±0.06 
Root Extract 
(50mg) 
7.86 ±0.10  11.8 ± 
0.89 
10482 ±57.23  21.6 
±0.10 
11.8± 0.13  37± 
0.36 
61 ±0.63  2 ±0.06 
Root Extract  
(100mg) 
8.15 ±0.08  10.7± 
0.03 
9876 ±37.97  19.8 
±0.07 
10.9± 0.04  44± 
0.50 
53 ±0.37  3 ±0.10 
 
 
Number of animals : 5 in each group 
Days of drug treatment:9 
Values were expressed as mean ± SE  
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